Forward Looking Statements

Any Ardelyx, Inc. (“Ardelyx”) website may contain forward looking statements, including statements regarding Ardelyx’s future financial performance, product pipeline and strategy.  Forward-looking statements involve substantial risks and uncertainties that could cause Ardelyx’s future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements.  Such risks and uncertainties include, among others, the uncertainties associated with the drug development process, the regulatory approval process and uncertainties in the drug commercialization process.  For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Ardelyx’s business in general, please refer to our most recent periodic report on Form 10-Q or Form 10-K filed with the Securities and Exchange Commission (“SEC”), and any future current or periodic report we may file with the SEC.

Forward-looking statements speak only as of the date first made unless another date is indicated.  In light of the significant uncertainties in forward-looking statements, you should not regard such statements as a representation or warranty that we will achieve our objectives and plans in any specified timeframe, and you should not place undue reliance on any forward-looking statements.  While we may update certain forward-looking statements from time to time, we specifically disclaim any obligation to do so, whether as a result of new information, future developments or otherwise.

Nothing in the website constitutes investment advice, including our SEC filings.  We provide investor relations materials for your convenience and information only.  In addition, investor relations materials and our other website content are not offers to sell or solicitations of an offer to buy any security.  There are no guarantees about the future performance of the stock market or our stock.  Before you invest in any security, you are urged to consult with a qualified financial advisor.